<--- Back to Details
First PageDocument Content
Mind / Mood disorders / Major depressive disorder / Bipolar disorder / Treatment of bipolar disorder / Antidepressant / Depression / Serotonin–norepinephrine–dopamine reuptake inhibitor / Bipolar disorders research / Psychiatry / Medicine / Abnormal psychology
Date: 2013-05-06 12:27:57
Mind
Mood disorders
Major depressive disorder
Bipolar disorder
Treatment of bipolar disorder
Antidepressant
Depression
Serotonin–norepinephrine–dopamine reuptake inhibitor
Bipolar disorders research
Psychiatry
Medicine
Abnormal psychology

Pioneering Solutions for Depression and Bipolar Disorder The Stanford Mood Disorders Center Campaign for Stanford

Add to Reading List

Source URL: psychiatry.stanford.edu

Download Document from Source Website

File Size: 4,56 MB

Share Document on Facebook

Similar Documents

The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS

The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS

DocID: 1sHB2 - View Document

Health Net Behavioral Health Benefit Plan

Health Net Behavioral Health Benefit Plan

DocID: 1rmb0 - View Document

Newsletter June 2016 We would like to draw your attention to the Call for Applications:

Newsletter June 2016 We would like to draw your attention to the Call for Applications: "IZA/DFID Short Course on Programme Evaluation" deadline which is June 30th__________________________________________________

DocID: 1r8XM - View Document

This list of services may change from year to year and are unique to Blue Cross Community Centennial:  

This list of services may change from year to year and are unique to Blue Cross Community Centennial:  

DocID: 1qObB - View Document

Newsletter 19 (Summer 2016)V3.pub

Newsletter 19 (Summer 2016)V3.pub

DocID: 1qylx - View Document